Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
Not Confirmed
Not Confirmed
19-22 May, 2025
Not Confirmed
Not Confirmed
20-22 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
Industry Trade Show
Not Confirmed
19-22 May, 2025
Industry Trade Show
Not Confirmed
20-22 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
05 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250505327840/en/CORRECTION-MAIA-Biotechnology-Announces-%241.08-Million-Private-Placement
01 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250401656979/en/MAIA-Biotechnology-CEO-Details-Anticipated-Clinical-Milestones-for-Novel-Cancer-Immunotherapy-in-2025-Letter-to-Shareholders
25 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250325817866/en/MAIA-Biotechnology-Announces-Poster-Presentation-at-ESMOs-European-Lung-Cancer-Congress-2025
20 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250320213464/en/MAIA-Biotechnology-Announces-Publication-of-Peer-Reviewed-Study-Featuring-Potency-and-Potential-of-Novel-THIO-Prodrug
19 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250319291660/en/MAIA-Biotechnology-Receives-USAN-Council-Approval-for-Ateganosine-as-Nonproprietary-Name-for-Anticancer-Agent-THIO
27 Feb 2025
// BUSINESSWIRE
ABOUT THIS PAGE